π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2000-06
Trial ID
NCT00005833
Treatments Being Tested
This phase I/II trial is studying the side effects and best dose of erlotin...
Status
Completed
Location
University of California at Los Angeles
Start Date
2006-04
Trial ID
NCT00335764
Treatments Being Tested
Phase II study designed to investigate antitumor activity in terms of objec...
Status
Completed
Location
Stanford University Medical Center
Start Date
2016-02-25
Trial ID
NCT02464228
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cytarabine, daunorubicin, an...
Status
Terminated
Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Start Date
2006-03
Trial ID
NCT00124644
This phase I trial is studying the side effects and best dose of tipifarnib...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2006-08
Trial ID
NCT00383474
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Mayo Clinic in Florida
Start Date
2002-11
Trial ID
NCT00005989
Treatments Being Tested
A Phase I, open-label clinical pharmacology study designed to evaluate the ...
Status
Terminated
Location
Gabrail Cancer Center Research
Start Date
2021-05-06
Trial ID
NCT04865159
Treatments Being Tested
The purpose of this study is to compare the effectiveness of gemcitabine wi...
Status
Completed
Location
Multiple Locations
Start Date
1999-11
Trial ID
NCT00005648
Treatments Being Tested
The purpose of this study is to determine the effectiveness of tipifarnib i...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT00093990
Treatments Being Tested
The purpose of this study is to determine if the addition of tipifarnib to ...
Status
Completed
Location
Multiple Locations
Start Date
2002-09
Trial ID
NCT00050141
Treatments Being Tested